HealthUnited StatesHighScore 7.0

US Health Secretary Kennedy distances himself from FDA rejection of Replimune cancer drug. The agency's decision to deny approval for the treatment has prompted a public separation from the administration's top health official.

US Health Secretary Kennedy has distanced himself from the FDA's decision to reject the cancer drug developed by Replimune.

What happened

US Health Secretary Kennedy has distanced himself from the FDA's decision to reject the cancer drug developed by Replimune.

Quick reaction

One tap helps tune what we surface next.

Reader discussion

Public comments
0/1000

No comments yet. Start the discussion around this signal.

Follow this signal

Get updates on this story

We will email you if this changes materially. No spam. Daily brief optional.

Map context

Open map near United States

Keep the story in context with nearby live signals, countries, and category movement.

Open live map

Related coverage

More live signals

Continue with the live feed.

The fastest nearby updates load from the public feed, not the enriched story endpoint.

Continue with live feed

Newsletter

Get the daily disruption briefing.

A concise ZettaWire email with the strongest global signals, links to canonical stories, and what to watch next.

Monitor

Track follow-ups in Monitor

Turn this public story into a watchlist seed for matching future signals, team alerts, and operational routing.

Signals API

Use these signals via API

Evaluate structured event payloads, canonical URLs, categories, geo fields, and confidence metadata for your own workflows.